Share ownership ResMed, Inc.

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 02:30:02 06/12/2025 am IST			5-day change	1st Jan Change
256.55 ^USD	+2.00%		+0.28%	+12.18%

05/12	Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	MT
02/12	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI

Share class: ResMed, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	19,00,59,825	14,56,58,162 ( 76.64 %)	4,31,92,913 ( 22.73 %)	76.64 %

Major shareholders: ResMed, Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 13.04 %	1,90,40,440	13.04 %	4 871 M $
BlackRock Advisors LLC 6.707 %	97,89,999	6.707 %	2 505 M $
STATE STREET CORPORATION 4.487 %	65,49,164	4.487 %	1 675 M $
BNY Mellon Investment Adviser, Inc. 3.119 %	45,53,022	3.119 %	1 165 M $
Geode Capital Management LLC 2.913 %	42,51,688	2.913 %	1 088 M $
Eaton Vance Management 1.585 %	23,13,138	1.585 %	592 M $
BlackRock Life Ltd. 1.55 %	22,62,601	1.55 %	579 M $
Invesco Advisers, Inc. 1.457 %	21,26,066	1.457 %	544 M $
Northern Trust Global Investments Ltd. 1.035 %	15,10,150	1.035 %	386 M $
Norges Bank (13F) 0.8137 %	11,87,798	0.8137 %	304 M $
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Australian Foundation Investment Co. Ltd. (Invt Mgmt) 0.4403 %	64,26,989	0.4403 %	166 M $
BetaShares Capital Ltd. 0.3105 %	45,32,079	0.3105 %	117 M $
AllianceBernstein Investments Taiwan Ltd. 0.2958 %	43,17,000	0.2958 %	111 M $
Australian United Investment Co. Ltd. (Investment Management) 0.1165 %	17,00,000	0.1165 %	44 M $
abrdn Fund Managers Ltd. 0.1006 %	14,68,183	0.1006 %	38 M $
Russell Investment Management Ltd. 0.0986 %	14,39,276	0.0986 %	37 M $
Airlie Funds Management Pty Ltd. 0.0828 %	12,08,877	0.0828 %	31 M $
AllianceBernstein Australia Ltd. 0.0711 %	10,37,600	0.0711 %	27 M $
Diversified United Investment Ltd. (Investment Management) 0.0685 %	10,00,000	0.0685 %	26 M $
Investors Mutual Ltd. 0.0434 %	6,33,216	0.0434 %	16 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	72.28%
Other	5.17%
State Street Corp.	4.49%
Individuals	0.53%
Swedbank AB	0.37%
Schweizerische Nationalbank	0.29%
Sumitomo Mitsui Trust Group, Inc.	0.26%
Governments	0.14%
Danske Bank A/S	0.11%
SEI Investments Co.	0.11%
Skandinaviska Enskilda Banken AB	0.06%
Manulife Financial Corp.	0.06%
ABN AMRO Bank NV	0.03%
Banco Bilbao Vizcaya Argentaria SA	0.03%
Harel Insurance Investments & Financial Services Ltd.	0.02%
The Bank of Nova Scotia	0.01%
Baader Bank AG	0.01%
Fifth Third Bancorp	0.01%
Zurich Insurance Group AG	0.01%
Univest Financial Corp.	0.01%
Unknown	16%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	48.2%
Australia	14.73%
United Kingdom	7.44%
Taiwan	2.96%
Canada	2.09%
Sweden	1.06%
Norway	1%
Switzerland	0.98%
Denmark	0.78%
Japan	0.78%
France	0.71%
Individuals	0.53%
Hong Kong	0.48%
Netherlands	0.43%
Ireland	0.37%
Luxembourg	0.31%
South Korea	0.21%
Italy	0.2%
Germany	0.19%
Austria	0.12%
New Zealand	0.1%
Finland	0.05%
Spain	0.05%
Belgium	0.04%
Singapore	0.04%
Malaysia	0.04%
Czech Republic	0.03%
Israel	0.02%
South Africa	0.02%
Liechtenstein	0.01%
Slovenia	0.01%
China	0.01%

Based on 1000 largest holdings

ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.

Employees

10,600

Sector

Advanced Medical Equipment & Technology

Calendar

22/01 - Q2 2026 Earnings Release (Projected)

More about the company